Periodontitis promotes intestinal inflammation through gut microbiota–mediated suppression of GPR109A
Frontiers in Cellular and Infection Microbiology · 24.02.2026 · 16
DOI: 10.3389/fcimb.2026.1761932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 24.02.2026. Verfasst von Xinyue Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Periodontitis, Gastrointestinal Microbiome, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To determine whether periodontitis promotes intestinal inflammation through gut microbiota–mediated suppression of the GPR109A receptor.
Methods
Periodontitis was induced by ligatures in C57BL/6J mice under normal chow or high-fructose diet. Periodontal destruction was evaluated by micro-computed tomography and hematoxylin and eosin staining. Colonic GPR109A expression, intestinal epithelial integrity, as well as intestinal and systemic inflammation were assessed by histology and immunostaining, quantitative polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assay (ELISA). Short-chain fatty acids (SCFAs) in colonic contents were quantified by GC–MS/MS. Further, the probiotic strain CBM588 was supplemented to two groups of mice (CP/LP group) to alleviate periodontitis-induced inflammation, and GPR109A expression was detected. To investigate the role of periodontitis-associated gut microbiota, fecal microbiota from control (GF-CON) and ligatured (GF-LIG) mice were transplanted into germ-free recipients, and colonic GPR109A levels and inflammatory responses were analyzed. Finally, GPR109A function was modulated by administration of GSK256073 and mepenzolate bromide in ligatured mice, and corresponding changes in tight junctional integrity as well as intestinal and systemic inflammation were evaluated.
Results
Periodontitis significantly downregulated the expression of colonic GPR109A and disrupted the localization of ZO-1 and Occludin. Probiotic supplementation restored GPR109A expression and rescued ZO-1 distribution. Fecal microbiota transplantation from periodontitis donors led to GPR109A suppression, tight junction impairment, and inflammatory upregulation in germ-free mice, confirming a microbiota-dependent mechanism. Activation of GPR109A reversed barrier disruption and reduced pro-inflammatory cytokine levels.
Conclusion
Periodontitis promotes colonic inflammation by gut microbiota-induced suppression of GPR109A receptor, leading to the destruction of the epithelial barrier. Activation of GPR109A restores barrier function and attenuates inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, China.
- School of Medicine, Nankai University, Tianjin, China.
Zitieren
APA
Wang, X., Xu, Z., Yao, Y., Jia, H., Du, M., Wang, S., Yan, F., & Li, L. (2026). Periodontitis promotes intestinal inflammation through gut microbiota–mediated suppression of GPR109A. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1761932
Vancouver
Wang X, Xu Z, Yao Y, Jia H, Du M, Wang S, et al. Periodontitis promotes intestinal inflammation through gut microbiota–mediated suppression of GPR109A. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1761932
BibTeX
@article{Wang2026,
author = {Wang, Xinyue and Xu, Zhonghan and Yao, Yujie and Jia, Hui and Du, Meng and Wang, Shuangzheng and Yan, Fuhua and Li, Lili},
title = {Periodontitis promotes intestinal inflammation through gut microbiota–mediated suppression of GPR109A},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1761932}
}
EUVIMED